Last mentioned: 2h ago
Across the most recent 5 stories covering Nasdaq — 40% positive, 60% neutral sentiment, averaging 6.6/10 impact.
This entity profile aggregates every story where the entity meets our minimum relevance threshold before it is linked here — a story naming this entity only in passing, as competitive context for an unrelated subject, does not qualify. That threshold exists because earlier testing surfaced entity pages cluttered with tangential mentions: a story about two unrelated companies merging could otherwise populate a third company's page simply because it was named once for comparison, with no real event of its own. The timeline below reflects genuine milestones and developments specific to this entity, cross-referenced against the same source-verification standard applied to every story on this site. Sentiment measures the directional read of each development for this entity specifically, not the overall tone of the reporting, and impact weights how consequential a development is rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Pilot Program
Expected launch of a pilot program for select S&P 500 stocks on the new DLT infrastructure.
Compliance Demands & Legal Pursuit Announced
Company announces it will submit compliance demands to clearinghouses and prime brokers ahead of mandatory legal action for FTDs and volume anomalies, and unveils a forensic audit strategy.
Retention of Christian Attar
DBGI retained the law firm Christian Attar to investigate potential naked short selling and market manipulation of its common shares.
SEC Approval
The SEC grants Nasdaq the authority to move public equity settlement to a blockchain ledger.
ICE Announcement
Intercontinental Exchange reveals development of a platform for on-chain settlement of securities.
Initial Filing
Nasdaq files a proposal with the SEC to amend rules for tokenized trading on its main market.
T+1 Implementation
U.S. markets transition to a one-day settlement cycle to reduce systemic risk.
Linq Launch
Nasdaq successfully completes its first private share trade using blockchain technology.
Indian experts argue Fidelity's 15-day lock on SpaceX IPO shares violates investor rights, while SEBI's regulatory framework would never permit such a restriction. A legal analysis of broker-imposed trading limits and investor protection.
Source: newkerala.com · prokerala.com
Digital Brands Group escalates its fight against alleged naked short selling by demanding compliance from clearinghouses and threatening litigation, backed by a forensic audit and the retention of boutique law firm Christian Attar. The move signals a rare issuer-led enforcement initiative targeting cross-border settlement anomalies and FTDs, with significant implications for securities regulation and civil liability theories.
Source: Financialcontent · Businesswire
The SEC has officially approved Nasdaq's proposal to integrate blockchain technology into its core trading infrastructure, marking a historic shift toward real-time settlement. This move transitions the traditional T+1 settlement cycle toward an 'atomic' model, potentially saving billions in collateral requirements and reducing systemic risk.
Source: proactiveinvestors.com · finance.yahoo.com
The U.S. Securities and Exchange Commission (SEC) has approved a landmark proposal by Nasdaq to allow certain stocks and exchange-traded products to be traded and settled in tokenized form. This decision marks a significant integration of blockchain technology into mainstream equity markets, initially targeting high-volume securities within the Russell 1000 Index and major benchmark ETFs.
Source: The Star Online (my) · Channelnewsasia
Corcept Therapeutics (NASDAQ: CORT) is the target of a class action lawsuit alleging securities fraud between October 2024 and December 2025. The Rosen Law Firm is leading the litigation, which centers on claims that the company misled investors regarding its business operations and regulatory compliance. This legal challenge marks a critical period of scrutiny for the pharmaceutical firm's corporate governance and public disclosure practices.
Source: Finger Lakes Times · Pr Newswire
This page surfaces every story mentioning Nasdaq across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.
Entities only appear on this page once the classifier scores them at a minimum 35 percent relevance to the story, filtering out passing mentions. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Nasdaq was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |